Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Oncology|January 15, 1998
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanomaD Bafaloukos, G Fountzilas, D Skarlos, et al.
Chemotherapy|January 1, 1995
Comparison of different schedules of ondansetron (GR 38032F) administration during cisplatin-based chemotherapy: a randomized trialN B Tsavaris, E Tsaroucha-Noutsou, N Karvounis, et al.
Oncology|April 15, 1999
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic cooperative oncology group studyD Bafaloukos, G Aravantinos, G Samonis, et al.
American Journal of Clinical Oncology|December 1, 1994
Comparison of ondansentron (GR 38032F) versus ondansentron plus alprazolam as antiemetic prophylaxis during cisplatin-containing chemotherapyN Tsavaris, G Charalambidis, M Pagou, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Predictive factors in radiotherapy for non-small cell lung cancer: present statusN Choi, M Baumann, M Flentjie, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approachN B Tsavaris, P Komitsopoulou, P Karagiaouris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. A Hellenic Co-operative Oncology Group StudyG Fountzilas, P Kosmidis, M Beer, et al.
Oncology|October 21, 1998
A randomized comparative study of antiemetic prophylaxis with ondansentron in a single 32-mg loading dose versus 8 mg every 6 h in patients undergoing cisplatin-based chemotherapyN Tsavaris, G Fountzilas, N Mylonakis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1992
Prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with colorectal cancerN Tsavaris, D Tsigalakis, A Bobota, et al.
Anti-Cancer Drugs|August 1, 1995
5-Fluorouracil, folinic acid and cisplatin in advanced colorectal cancer: a pilot studyN Tsavaris, K Tentas, C Bacoyiannis, et al.
Pageof 15